Bryan Gilburg - China

“Medical Device Registrants in Thailand can look forward to reduced regulatory documentation under Full and Concise Evaluation pathways.”

Noi Suwannabot

General Manager, Asia Actual Thailand

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Important Documents and Links

Sign Up For Our Newsletter to Stay Informed

Sign Up

New Regulatory Documentation Exemptions in Thailand

Published: April 12th, 2024

On March 12th, 2024, the Thai FDA released draft guidance stating their intention to update the list of required documentation for Full and Concise Evaluation. For manufacturers registering qualifying medical devices in Thailand, certain documents will no longer required. Thailand has three regulatory pathways:

  1. Full Evaluation (CSDT)
  2. Concise Evaluation (expedited review program)
  3. Singapore Reliance Program (expedited review program)

Only Full and Concise Evaluations will be impacted by this draft.

Full and Concise Documentation Exemptions

Full Evaluations will no longer require;

  1. Letter of certification of the intended use/indication/packaging, Letter of certification of label and instruction for use from manufacturer or product owner
  2. Safety declaration
  3. Marketing history declaration
  4. Proof of approval from authority in foreign countries

Concise Evaluation will no longer require;

  1. Design verification and validation documents
  2. Risk analysis
  3. Destruction method

Medical devices and IVDs that qualify for a Concise evaluation will receive an expedited review. To see whether your medical device or IVD qualifies for a concise evaluation, visit our blog post about concise evaluations in Thailand here.

With regards to questions or comments,  feel free to contact Asia Actual today.

Come Grow with Us

Please contact Asia Actual with any questions or requests for support in Thailand. We have offices staffed by experienced, bilingual regulatory and commercial professionals in the major capital cities of Asia. Our mission is to provide a stable, reliable local platform so that our clients can grow their sales in challenging Asian markets.

Blog Posts

Indonesia invests more in Healthcare via a Hospital-based education system

Indonesia Invests in Quality Healthcare Access

On May 6th, 2024 the President of Indonesia, Joko Widodo launched the new hospital-based Specialist Doctor Education Program which supports Indonesia's growing commitment to the healthcare industry and provides strong support for investment in Indonesia. 
Indonesia increases healthcare investment via 6 pillar transformation health policy

Indonesia Boosts Medical Device Sales Prospects

Recent developments have made the Indonesian market an even more attractive place to generate medical device sales growth.
GPDMD in Indonesia

Indonesia Implements GDPMD Requirement

On April 30th, 2024, the Ministry of Health in Indonesia announced that it will be implementing a Good Distribution Practice of Medical Devices (GDPMD) requirement.